DK1382346T3 - Konditioneret medium og diffunderbare biologiske produkter fremstillet ved inkubering af indesluttede celler - Google Patents

Konditioneret medium og diffunderbare biologiske produkter fremstillet ved inkubering af indesluttede celler

Info

Publication number
DK1382346T3
DK1382346T3 DK03018701T DK03018701T DK1382346T3 DK 1382346 T3 DK1382346 T3 DK 1382346T3 DK 03018701 T DK03018701 T DK 03018701T DK 03018701 T DK03018701 T DK 03018701T DK 1382346 T3 DK1382346 T3 DK 1382346T3
Authority
DK
Denmark
Prior art keywords
conditioned medium
incubating
biological products
products prepared
agarose
Prior art date
Application number
DK03018701T
Other languages
Danish (da)
English (en)
Inventor
Kanti Jain
Albert Rubin
Shirin Asina
Barry Smith
Kurt Stenzal
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/745,063 external-priority patent/US5888497A/en
Application filed by Rogosin Inst filed Critical Rogosin Inst
Application granted granted Critical
Publication of DK1382346T3 publication Critical patent/DK1382346T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
DK03018701T 1996-04-03 1997-03-21 Konditioneret medium og diffunderbare biologiske produkter fremstillet ved inkubering af indesluttede celler DK1382346T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62559596A 1996-04-03 1996-04-03
US08/745,063 US5888497A (en) 1996-04-03 1996-11-07 Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
PCT/US1997/004548 WO1997036495A1 (en) 1996-04-03 1997-03-21 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof

Publications (1)

Publication Number Publication Date
DK1382346T3 true DK1382346T3 (da) 2008-01-28

Family

ID=27089961

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97915180T DK0914043T3 (da) 1996-04-03 1997-03-21 Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf
DK03018701T DK1382346T3 (da) 1996-04-03 1997-03-21 Konditioneret medium og diffunderbare biologiske produkter fremstillet ved inkubering af indesluttede celler

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK97915180T DK0914043T3 (da) 1996-04-03 1997-03-21 Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf

Country Status (16)

Country Link
EP (2) EP0914043B1 (ja)
JP (2) JP3765039B2 (ja)
CN (2) CN1296477C (ja)
AT (2) ATE250858T1 (ja)
AU (1) AU722109C (ja)
CA (1) CA2250880C (ja)
DE (2) DE69738170T2 (ja)
DK (2) DK0914043T3 (ja)
ES (2) ES2290390T3 (ja)
FI (1) FI120332B (ja)
HK (2) HK1019037A1 (ja)
IL (1) IL126442A0 (ja)
NO (1) NO320334B1 (ja)
NZ (2) NZ331960A (ja)
PT (1) PT914043E (ja)
WO (1) WO1997036495A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303151B1 (en) * 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
NO983911D0 (no) 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
AU2003264652B2 (en) * 1998-11-09 2006-09-14 The Rogosin Institute Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US9308252B2 (en) 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9283266B2 (en) 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
RU2591518C2 (ru) * 2012-01-31 2016-07-20 Де Рогозин Инститьют Инк. Усовершенствованный способ получения макрогранул
EP3746785A4 (en) * 2018-02-02 2022-05-11 Wake Forest University Health Sciences, Inc. IMMUNOTHERAPY RELATED ORGANOIDS AND METHODS OF PREPARING AND USING THEREOF

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
CA1196862A (en) * 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
SE8604684L (sv) * 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JP2691557B2 (ja) * 1988-04-15 1997-12-17 興研株式会社 人の悪性腫瘍細胞増殖抑制剤
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5241051A (en) * 1992-04-24 1993-08-31 Research Development Foundation Oncoinhibin
NZ278809A (en) * 1994-01-13 1998-03-25 Rogosin Inst Macroencapsulation of secretory cells in an agarose collagen gel material coated with agarose
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles

Also Published As

Publication number Publication date
EP1382346A1 (en) 2004-01-21
CA2250880C (en) 2008-01-15
AU722109C (en) 2001-07-19
DE69725317D1 (de) 2003-11-06
CN1215309A (zh) 1999-04-28
ES2290390T3 (es) 2008-02-16
JP4480152B2 (ja) 2010-06-16
FI981957A (fi) 1998-12-02
AU722109B2 (en) 2000-07-20
EP1382346B1 (en) 2007-09-26
HK1019037A1 (en) 2000-01-21
WO1997036495A1 (en) 1997-10-09
DE69725317T2 (de) 2004-07-29
NO984627L (no) 1998-11-30
NO984627D0 (no) 1998-10-02
CN1119080C (zh) 2003-08-27
EP0914043B1 (en) 2003-10-01
PT914043E (pt) 2004-02-27
AU2218897A (en) 1997-10-22
NZ331960A (en) 1999-10-28
JP2001503380A (ja) 2001-03-13
FI120332B (fi) 2009-09-30
ES2206696T3 (es) 2004-05-16
JP2005104987A (ja) 2005-04-21
HK1066026A1 (en) 2005-03-11
ATE250858T1 (de) 2003-10-15
CN1296477C (zh) 2007-01-24
CN1495253A (zh) 2004-05-12
CA2250880A1 (en) 1997-10-09
EP0914043A4 (en) 2001-08-29
ATE374034T1 (de) 2007-10-15
NZ337109A (en) 2004-12-24
DE69738170D1 (de) 2007-11-08
EP0914043A1 (en) 1999-05-12
IL126442A0 (en) 1999-08-17
DK0914043T3 (da) 2004-02-09
JP3765039B2 (ja) 2006-04-12
DE69738170T2 (de) 2008-01-24
NO320334B1 (no) 2005-11-21
FI981957A0 (fi) 1998-09-11

Similar Documents

Publication Publication Date Title
DE69534151D1 (de) Gefriergetrocknete Blutzellen, Stammzellen und Plättchen und Verfahren zu deren Herstellung
DK1382346T3 (da) Konditioneret medium og diffunderbare biologiske produkter fremstillet ved inkubering af indesluttede celler
IL68941A0 (en) Method for immobilizing biological materials,composite materials produced thereby and their use
AU619110B2 (en) Microbiological dry culture medium
PT1382346E (pt) Meio condicionado e produto biológico difusível produzido por incubaçâo de células aprisionadas
AU1997788A (en) Filtration unit, in particular for medical specimens
NO872881D0 (no) Fremgangsmaate for bestemmelse av skjult blad i proever fra mennesker.
AU1828388A (en) Promoters for the expression of foreign dna in methylotrophic bacteria, the obtaining thereof and the use thereof
DE59010759D1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
NO970136D0 (no) Granulös formulering inneholder mikroorganismer, fremgangsmåte for fremstilling og anvendelse derav
ATE41654T1 (de) All-cis-1,3,5-triamino2,4,6-cyclohexantriolderivate, ihre verwendung, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE59008610D1 (de) Verbundmembran, verfahren zu ihrer herstellung und ihre verwendung.
DE68919259D1 (de) N-Phenylimide, ihre Herstellung und Verwendung.
DE59010331D1 (de) Pyridin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide
AU3188089A (en) Method for detecting antibodies in blood, and membrane strip and membrane battery for use when carrying out the method
FI972624A0 (fi) 14alfa,17alfa-C2-sillan sisältäviä 19-norprogesteronijohdoksia
DK0804098T3 (da) Filter til tobaksrøg
AU3845395A (en) Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof
DE3675142D1 (de) Heterocyclische pentalenderivate zur verwendung bei der bekaempfung von mikroorganismen.
AU7001798A (en) Substituted 3-benzylpyrazoles and their use as herbicides and for lowering the sugar content in blood
DE59008697D1 (de) Bis-Phthalidlaktone, Verfahren zu deren Herstellung und ihre Verwendung in Aufzeichnungsmaterialien.
ATE102787T1 (de) Kultursystem und behaelter zur verwendung in diesem system.
FR2649609B1 (fr) Composition destinee aux soins corporels. procede de preparation, utilisation et application
ATE74968T1 (de) Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens.
IT234231Y1 (it) Contenitore per analisi microbiologiche